Background 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) is used in
the differential diagnosis and staging of extrahepatic bile duct cancer (EBDC), but its …

Malignant tumors with high glucose metabolic rates accumulate [18F]–fluorodeoxyglucose
(FDG), a positron emitting tracer. The aim of this study was to evaluate FDG positron …

Purpose The aim of this study was to assess the value of dual–time point PET/CT in the
differentiation of extrahepatic cholangiocarcinoma from benign stricture and the added …

18F-Fluorodeoxyglucose positron-emission with computed tomography (18F-FDG PET-CT)
is an imaging technique based on the increased uptake of glucose characteristically seen in …

Background. In advanced biliary tract cancer (BTC), the metabolic landscape has not been
evaluated by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) yet …

Resectional surgery offers a curative intent and a survival benefit for patients with hilar
cholangiocarcinoma, but is associated with high morbidity. Since morphological imaging …

This meta-analysis was performed to determine the diagnostic accuracy of 18F-
fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in assessing primary …

Purpose In this prospective study, our goal was to emphasize the diagnostic value of
combining 11 C-choline and 18 F-FDG PET/CT for hepatocellular carcinoma (HCC) in …

Background The purpose of the current study was to evaluate the accuracy of 18F‐FDG
PET/CT in staging hilar cholangiocarcinoma. Materials and Methods From June 2004 to …

Purpose Intrahepatic cholangiocarcinoma (IHC) is an aggressive disease with few reliable
preoperative biomarkers. This study aims to elucidate if radiomics extracted from …